lh-theme
primary-extra-dark
lh-content-width
xl
lh-padding-top
sm
lh-padding-bottom
md

Adjudicating Claims for COVID-19 Vaccines, their Administration and COVID-19 Monoclonal Antibodies

lh-theme
primary-extra-dark
lh-content-width
xl
lh-padding-top
none
lh-padding-bottom
md
October 21, 2021
group-label
Button Group
size
md
orientation
horizontal
alignment
center
button-type
lh-button
variant
text
text
Ancillary
media-label
label
link
Ancillary
icon-position
right
full-width
false
full-width-mobile
false
button-type
lh-button
variant
text
text
Pharmacy
media-label
label
link
Pharmacy
icon-position
right
full-width
false
full-width-mobile
false
button-type
lh-button
variant
text
text
COVID 19
media-label
label
link
COVID 19
icon-position
right
full-width
false
full-width-mobile
false
lh-theme
primary-extra-dark
lh-padding-top
none
lh-padding-bottom
md
lh-spacing
tight

Please note, this communication applies to Healthy Blue + MedicareSM (HMO D-SNP) offered by Blue Cross and Blue Shield of North Carolina.

Beginning January 1, 2022, Medicare Advantage Organizations (MAOs) and Medicare Medicaid Plans (MMPs) are responsible for adjudicating claims for COVID-19 vaccines and their administration and for COVID-19 monoclonal antibodies and their administration. Compensation for these services will be based on the provider's contract.

See more details and resources about Healthy Blue + Medicare on our website.

BNCCARE-0226-21 October 2021

lh-theme
neutral-light
lh-content-width
md
lh-padding-top
xl
lh-padding-bottom
xl